Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    -24.00 (-1.88%)
Bid:
1,246.00
Ask:
1,258.00
Spread: 12.00 (0.963%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Holding(s) in Company

4 Nov 2024 17:42

RNS Number : 8882K
Cohort PLC
04 November 2024
 

Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares:

Cohort PLC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of shares

X

An acquisition or disposal of financial instruments

An event changing the breakdown of shares outstanding

Other (please specify):

3. Details of person subject to the notification obligation

Name

Schroders PLC

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

30/10/2024

6. Date on which issuer notified (DD/MM/YYYY):

31/10/2024

7. Total positions of person(s) subject to the notification obligation

% of shares outstanding (total of 8. A)

% of shares outstanding through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of shares outstanding held in issuer

Resulting situation on the date on which threshold was crossed or reached

11.866909%

11.866909%

4,961,912.00

Position of previous notification (if

applicable)

12.98269%

12.98269%

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedv

A: Shares

Class/type ofshares

ISIN code (if possible)

Number of shares outstanding

% of shares outstanding

Direct

 

Indirect

 

Direct

 

Indirect

 

Equity: GB00B0YD2B94

4,961,912.00

11.866909%

SUBTOTAL 8. A

4,961,912.00

11.866909%

 

 

B 1: Financial Instruments as an entitlement to acquire

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number shares that may be acquired if the instrument is

exercised/converted.

% of shares outstanding

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Physical or cash

settlement

Number of shares

% of shares outstanding

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the shares and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity(please add additional rows as necessary)

X

Name

% of shares outstanding if it equals or is higher than the notifiable threshold

% of shares outstanding through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Schroders PLC

Schroder Administration Limited

Schroder Wealth Holdings Limited

Schroder & Co. Limited

Schroders PLC

Schroder Administration Limited

Schroder International Holdings Limited

Schroder Investment Management Limited

10.042673

10.042673

 

10. Additional information

 

Place of completion

London

Date of completion

31/10/2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUSSBRSAUARAA
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.